Mark E. Thomas

681 total citations
9 papers, 481 citations indexed

About

Mark E. Thomas is a scholar working on Nephrology, Surgery and Molecular Biology. According to data from OpenAlex, Mark E. Thomas has authored 9 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Mark E. Thomas's work include Chronic Kidney Disease and Diabetes (4 papers), Lipoproteins and Cardiovascular Health (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Mark E. Thomas is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Lipoproteins and Cardiovascular Health (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Mark E. Thomas collaborates with scholars based in United Kingdom and United States. Mark E. Thomas's co-authors include George F. Schreiner, John Walls, Kevin P.G. Harris, Peter Furness, Nigel J. Brunskill, Aubrey R. Morrison, J. H. Pringle, Elaine M. Bailey, J. B. Glen and Somanath Padhi and has published in prestigious journals such as Kidney International, BMJ and American Journal of Physiology-Renal Physiology.

In The Last Decade

Mark E. Thomas

8 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Thomas United Kingdom 6 259 154 91 78 57 9 481
Mitsumasa Nagase Japan 14 320 1.2× 108 0.7× 68 0.7× 68 0.9× 66 1.2× 50 634
Qingwen Wang China 13 363 1.4× 125 0.8× 85 0.9× 77 1.0× 61 1.1× 28 622
Nadya Mothu France 10 422 1.6× 95 0.6× 107 1.2× 75 1.0× 36 0.6× 11 689
Samantha Bonazzola Italy 7 280 1.1× 169 1.1× 65 0.7× 64 0.8× 25 0.4× 7 843
Shiwori Osada Japan 12 269 1.0× 125 0.8× 117 1.3× 31 0.4× 54 0.9× 26 518
Kevin S. Eardley United Kingdom 7 259 1.0× 176 1.1× 123 1.4× 121 1.6× 26 0.5× 8 665
Hiroyuki Kadoya Japan 15 213 0.8× 169 1.1× 95 1.0× 31 0.4× 39 0.7× 34 550
Jessica L. Friedrich United States 9 314 1.2× 170 1.1× 99 1.1× 52 0.7× 23 0.4× 10 557
S. Michael Mauer United States 9 302 1.2× 131 0.9× 82 0.9× 35 0.4× 23 0.4× 9 585
Insa E. Emrich Germany 14 269 1.0× 88 0.6× 131 1.4× 54 0.7× 52 0.9× 42 616

Countries citing papers authored by Mark E. Thomas

Since Specialization
Citations

This map shows the geographic impact of Mark E. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Thomas more than expected).

Fields of papers citing papers by Mark E. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Thomas. The network helps show where Mark E. Thomas may publish in the future.

Co-authorship network of co-authors of Mark E. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Thomas. A scholar is included among the top collaborators of Mark E. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Thomas. Mark E. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Rayner, Hugh C., Mark E. Thomas, & David V. Milford. (2020). Understanding Kidney Diseases. 5 indexed citations
2.
Padhi, Somanath, et al.. (2015). Management of anaemia in chronic kidney disease: summary of updated NICE guidance. BMJ. 350(jun04 6). h2258–h2258. 46 indexed citations
3.
Thomas, Mark E. & John F. Moorhead. (2015). Lipids in CAPD: A Review. Contributions to nephrology. 85. 92–99.
4.
Eardley, Kevin S., et al.. (2002). Transplant‐associated inflammatory breast disease. Nephrology Dialysis Transplantation. 17(3). 512–515. 2 indexed citations
5.
Thomas, Mark E., Kevin P.G. Harris, John Walls, Peter Furness, & Nigel J. Brunskill. (2002). Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. American Journal of Physiology-Renal Physiology. 283(4). F640–F647. 111 indexed citations
6.
Thomas, Mark E., Nigel J. Brunskill, Kevin P.G. Harris, et al.. (1999). Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy. Kidney International. 55(3). 890–898. 99 indexed citations
7.
Thomas, Mark E., Aubrey R. Morrison, & George F. Schreiner. (1995). Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. American Journal of Physiology-Renal Physiology. 268(6). F1177–F1184. 44 indexed citations
8.
Thomas, Mark E. & George F. Schreiner. (1993). Contribution of Proteinuria to Progressive Renal Injury: Consequences of Tubular Uptake of Fatty Acid Bearing Albumin. American Journal of Nephrology. 13(5). 385–398. 102 indexed citations
9.
Thomas, Mark E., Kevin P.G. Harris, Jane Hattersley, et al.. (1993). Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney International. 44(5). 1124–1129. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026